We've had some good times, but this account will soon be deleted. If you'd like to keep following me, please go to https://t.co/HdbLivOLgg and put your email in the box. Thanks!

Thailand's UHC is a success, providing quality healthcare with only 5% of GDP. HTA drives cost-effectiveness but faces challenges in early-stage innovation, equity, and sustainability. Find out more in the latest insight ‘Around the World in HTAs’ here: https://t.co/x8LfcGA1yI

Join us for a @healtheconomics webinar on Thursday, hosted by the Mental Health Economics SIG. We'll have 3 ECRs discussing research on measurement in mental health. 08:30 in the UK, 17:30 in Melbourne. https://t.co/S54oIi87Oe #healtheconomics

A Framework for Value-aligned Pricing of Combination Therapies! Our latest report proposes innovative pricing strategies to enhance patient access in Europe. Learn how combination-based differential pricing can drive value and affordability in healthcare. https://t.co/cCa73A3CJY

Next stop in our Around the World in HTA tour is the United States: @ChrisSampson87 and Dan Ollendorf consider the US's HTA system, looking at what it once was, the current role of HTA in decision-making, and new developments on the horizon. https://t.co/Jk1Oe5qYTs

With thanks for tolerating my delusions of grandeur 👍

You've waited 10 years, but here it is, the culmination of our 'drop dead' work and - hopefully - the dawn of a new era for research on the QALY

Did you know that the movie Blade Runner is actually about the EQ-5D? https://t.co/nx4cxUorV1

Daniel Kahneman’s (1934 – 2024) contributions to behavioural economics have significantly impacted health economics. His research on prospect theory challenged traditional assumptions around decision-making in healthcare. There is still much for economists to learn from his work.

Donate to @WCKitchen:

Applications are still open for the 2024 Innovation Policy Prize! Submit your ideas for a chance to win £40,000. Meet our esteemed Judging Panel led by Prof. Anita Charlesworth CBE. Register: https://t.co/kfOUXXZc1I

Tomorrow I'll chat to @JacolineBouvy, @adaviesABHI, and Matthijs Versteegh for an @OHENews webinar about the future of HTA on the occasion of @NICEComms's 25th birthday. Join us! https://t.co/YGyiCnYtiY #healtheconomics #healthpolicy #HTA

Today, Elf Economist @ChrisSampson87 evaluates a cost-of-illness analysis on the economic burden of OCD in the UK. https://t.co/UYanxtJrPs #OCD #Economics #Costs #HealthEconomics #HealthSpending #PrivateTherapy #SocietalCost #NHS

Applications are open! Apply to the 2024 Innovation Policy Prize Fund and explore how economic policies can drive environmentally sustainable innovation in life sciences. First round deadline is 13.05.24. Don't miss out on your chance to win £40k! https://t.co/tUdT9WI4Ri

Join our webinar "The Future of NICE in a Changing HTA Landscape" on 27 March 2024, celebrating @NICEComms 's 25th anniversary! Join us to discuss challenges and opportunities for the next 5-10 years with @ChrisSampson87. Save the date! https://t.co/B062S2iR3P

Marginal cost per QALY estimates: what are they good for? 🤔 Read our commentary challenging claims about the usefulness of these estimates in #HealthPolicy. (free for some time at the link below) 🔓 https://t.co/uhnhpH8nOv🔓 #healtheconomics

The Health Years in Total and Equal Value of Life Years Gained, two recently proposed alternatives to the #QALY, can lead to logically inconsistent decision making & should be avoided by decision makers. More at https://t.co/K0B5bE4GE4 @ISPORorg @mikepaulden @ChrisSampson87

Time for another mass walkout for @WileyEconomics, this time at the Journal of Economic Surveys. So nice to see the parasitic publishing industry destroying itself. Credit to the editors for quitting. https://t.co/7NLLiW0EUa

As the largest humanitarian organisation in📍#GazaStrip - we will do whatever possible to continue our indispensable work to support people in #Gaza Despite repeated calls, there is still no humanitarian ceasefire. At this critical moment #DonateToUNRWA: https://t.co/BAncZ2TnRb